Kala Pharmaceuticals KALA reported its Q2 earnings results on Thursday, August 11, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Kala Pharmaceuticals beat estimated earnings by 18.6%, reporting an EPS of $-0.35 versus an estimate of $-0.43.
Revenue was down $951 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.04 which was followed by a 0.16% drop in the share price the next day.
Here's a look at Kala Pharmaceuticals's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.36 | -0.41 | -0.43 | -0.45 |
EPS Actual | -0.40 | -0.68 | -0.43 | -0.57 |
Revenue Estimate | 3.07M | 3.41M | 5.16M | 5.33M |
Revenue Actual | 1.37M | 1.86M | 3.07M | 3.05M |
To track all earnings releases for Kala Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.